Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study

Meeraus W. et al, (2024), Journal of Infection, 88

Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study

Forbes AK. et al, (2024), eClinicalMedicine, 68

Hepatitis A vaccination coverage amongst people with Chronic Liver Disease in England (HEALD): protocol for a retrospective cohort study (Preprint)

Meza-Torres B. et al, (2023)

Hepatitis A vaccination coverage amongst people with Chronic Liver Disease in England (HEALD): protocol for a retrospective cohort study (Preprint)

Meza-Torres B. et al, (2023), JMIR Research Protocols

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study

Tsang RSM. et al, (2023), Journal of the Royal Society of Medicine

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

Tsang RS. et al, (2023), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 28

Sodium-glucose cotransporter-2 inhibitors and kidney outcomes in real-world type 2 diabetes populations: A systematic review and meta-analysis of observational studies

Forbes AK. et al, (2023), Diabetes, Obesity and Metabolism

Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study.

de Lusignan S. et al, (2022), Diabetes therapy : research, treatment and education of diabetes and related disorders

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people.

Dambha-Miller H. et al, (2022), Fam Pract

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).

Feher M. et al, (2022), JMIR Res Protoc, 11

Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study.

Dambha-Miller H. et al, (2022), Fam Pract

The Effect of the COVID-19 Pandemic on Glycemic Monitoring and Other Processes of Care for Type 2 Diabetes: Protocol for a Retrospective Cohort Study

Mathew M. et al, (2022), JMIR Research Protocols, 11

BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database

Lemanska A. et al, (2022), PloS one, 17

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study

Whyte MB. et al, (2022), Diabetes, Obesity and Metabolism

Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies

Hinton W. et al, (2022), Diabetes, Obesity and Metabolism

Effect of COVID-19 pandemic on glycaemic monitoring and other processes of care in Type 2 Diabetes: Protocol for a retrospective cohort study (Preprint)

Mathew M. et al, (2021)

Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality

Feher M. et al, (2021), Atherosclerosis, 339, 55 - 56

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis

Hinton W. et al, (2021), Cardiovascular Diabetology, 20

A wake-up call for preconception health: a clinical review

Stephenson J. et al, (2021), The British journal of general practice : the journal of the Royal College of General Practitioners, 71, 233 - 236

Diabetic retinopathy in newly diagnosed Type 2 diabetes mellitus: Prevalence and predictors of progression; a national primary network study

Shah S. et al, (2021), Diabetes Research and Clinical Practice, 175

Load More